Search Results

Business

Adimab Provides 2023 Update on Clinical Pipeline

Adimab, LLC today announced that 12 new partner programs entered clinical development in 2023.

January 9, 2024

·

5 min read

Press Releases

Adimab Announces Hire of Aaron Sato as Chief Strategy Officer

October 17, 2024

·

3 min read

Policy

Adimab Announces Successful Resolution of Lawsuit Brought Against LinkedUp Bioscience and Tianti Biotherapeutics

Adimab, LLC announced today that Adimab and LinkedUp Bioscience, Inc. (and related parties) have agreed to resolve litigation.

December 21, 2023

·

5 min read

Policy

LinkedUp Bioscience and TianTi Biotherapeutics Successfully Resolve Legal Dispute with Adimab

LinkedUp Bioscience and TianTi Biotherapeutics are pleased to announce the resolution of the lawsuit brought by Adimab, LLC, and related parties.

January 9, 2024

·

1 min read

Business

Adimab Provides Year-End Update on 2023 Partnership Activities

Adimab, LLC, the global leader in the discovery and engineering of fully human monoclonal and multispecific antibodies, today announced that it entered into partnership agreements with 10 new companies in 2023.

January 8, 2024

·

5 min read

Business

Ablexis Announces License Agreement with Adimab

Ablexis, LLC today announced a license agreement with Adimab, LLC (“Adimab”).

February 9, 2023

·

2 min read

Business

Ono Enters into a Drug Discovery Collaboration Agreement with Adimab to Discover Novel Antibody Drugs in the Oncology Field

Ono Pharmaceutical Co., Ltd. announced that it has entered into a drug discovery collaboration agreement with Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, to discover and develop innovative antibody drugs in the oncology field.

September 27, 2023

·

3 min read

Press Releases

Acella Pharmaceuticals, LLC, an Alora Pharmaceuticals, LLC Subsidiary, Partners with Paloma Health for Hypothyroidism Patients

October 23, 2024

·

2 min read

Adimab Provides Year-End Update on 2022 Partnership Activities

Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, today announced that it entered into partnership agreements with 11 new companies in 2022.

January 10, 2023

·

5 min read

Deals

INTEGRATED ONCOLOGY NETWORK ANNOUNCES THE ACQUISITION OF UROLOGY PARTNERS, LLC

Integrated Oncology Network, LLC (“ION”), a portfolio company of Silver Oak Services Partners, LLC (“Silver Oak”), today announced the acquisition of Urology Partners, LLC.

May 2, 2024

·

3 min read